Acrivon Therapeutics, Inc. (ACRV) stock
ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.56+0.13 (+9.09%)
Close on Nov 18, 2026Market cap $66.85MP/E –Yield –
Acrivon Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Acrivon Therapeutics's price to book ratio was 0.8× on Nov 11, 2026, against 0.6× a year earlier. Over the last 4 years it ranged from 0.2× to 2.6×, with a median of 0.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.8× | +0.2 |
| 2025 | Dec 31, 2025 | 0.6× | −0.4 |
| 2024 | Dec 31, 2024 | 1.0× | +0.2 |
| 2023 | Dec 29, 2023 | 0.8× | – |
See a number that looks wrong?